Clinical Biochemistry-Drug Delivery & Therapy (CB-DDT) Group from VHIR fosters research on new biomedical advanced therapies and nanotechnology-based systems
A pleasure to participate in the 20th anniversary of @etpnanomedicine today at the NanoMed Europe 2025 Conference! Building the Future of Nanomedicine! 💪🏻👩🏻🔬
A pleasure to participate in the 20th anniversary of @etpnanomedicine today at the NanoMed Europe 2025 Conference! Building the Future of Nanomedicine! 💪🏻👩🏻🔬
A #VallHebron-led research identifies a new therapeutic strategy to treat the #glioblastoma. The article, published in the Journal of the @CRSScience, focused on nanotechnology to find a delivery method that improves on current treatments.
https://t.co/zaRJy5zbZs
La Dra. Diana Fernandes de Rafael i Arthur Cardoso, investigadors del #VHIR, han estat seleccionats per les beques de postdoctorat Junior Leader i de doctorat INPhINIT de @FundlaCaixaCAT. Enhorabona! 👏
🔗 Més info: https://t.co/LROKSdLHkl
I am still overwhelmed by the great moment we lived yesterday at the La Caixa Fellowship Award Ceremony! @BecariosFLC@FundlaCaixa@VHIR_
@CIBERBBN
@Nanbiosis
Thank you for the way you make us feel so recognised.🥹💙
https://t.co/HY0mGWz2QC
👩 Les investigadores del VHIR apropen als infants la ciència sense perjudicis!
👏 Hem celebrat el dia de les Dones i les Nenes en la Ciència. #DivulgaCiènciaVH
🔬 L’11 de febrer se celebra el Dia Internacional de les Dones i les Nenes en la Ciència. Els instituts de recerca de l’#icscat han organitzat diverses activitats per inspirar les noves generacions i promoure referents femenins en la ciència.
#DiaDonaiNenaCiència
@NanomedSpain@IBECBarcelona@BegoBenito_ La Dra. Fernanda Raquel da Silva Andrade, IP del grup de Bioquímica Clínica, Vehiculització de Fàrmacs i Teràpia del #VHIR, explica un estudi per desenvolupar nanopartícules que travessin la barrera hematoencefàlica i permetin millorar el tractament del glioblastoma.
,🔊Tomorrow Dr. Fernanda Andrade will present the advances of her project related with the use of Nanoparticles to Glioblastoma Treatment in the scope of the 🧪Nano World Cancer Day🔬! @NanomedSpain See the program and Register Below!
https://t.co/m9SDJzfFOC
Our new #CEBS is now available!
🔬Custom synthesis of peptides and in vivo validation to revolutionize nanomedicine with precision drug delivery!
https://t.co/VPB45wJsFY
Last week to send proposals to our Open Call! Info in our web
#CEBiomedS#NanbiosisExpertise#ICTSnews
What an overwhelming experience! I couldn't be more happy and thankful for this opportunity. Thank you to all my colleagues and thank you @BecariosFLC for the way you take care of us, for the trust and for preparing us for the future!🥹💙
See you on March!
@VHIR_
@CIBERBBN
. @vallhebron participa en el Project-COMFORT amb l’objectiu de desenvolupar una tecnologia innovadora de micromostreig, fent que la recollida de sang sigui més accessible i centrada en el pacient.
🔗 https://t.co/ldguTNdBDT
🚀 #IBEC hosted the #SPM40 kick-off meeting, an @MSCActions project advancing autonomous #SPM with #AI to revolutionize life sciences!
🔬 Led by @GomilaIBECLab, it unites 22 partners to train 16 researchers in diagnostics & nanoscopic imaging.
Read more: https://t.co/cBcP3wgVSj
Kick-off Meeting of the MSCA Doctoral Network Project "Autonomous Scanning Probe Microscopy for Life Sciences and Medicine powered by Artificial Intelligence" - SPM4.0 at @IBECBarcelona.
Soon we will share the project web! Stay connected!
@PCB_UB @CIBERBBN @VHIR
🏆Congratulations to Dra. Fernanda Andrade and all the Team for this project that focuses on finding new therapeutic strategies against cerebral arteriovenous malformations.
https://t.co/sj3BXLZ7iz
@CIBERBBN @Nanbiosis@CaixaResearch@FundlaCaixa
Las malformaciones arteriovenosas cerebrales son una de las principales causas de accidente cerebrovascular hemorrágico en niños y jóvenes. Con #CaixaResearch de Investigación en Salud (@CaixaResearch@FundlaCaixa), @vallhebron buscará nuevas terapias.
🔗https://t.co/Sfd500ov5b